Sinocelltech Group

Sinocelltech Group Equity

The Equity of Sinocelltech Group (688520.SS) as of Oct 25, 2026.

Equity

-CNY

Last updated:

In 2026, Sinocelltech Group's equity was - CNY, a % increase from the - CNY equity in the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sinocelltech Group Stock analysis

What does Sinocelltech Group do? Sinocelltech Group Ltd, based in Beijing, China, operates in the Health Care sector with a focus on biotechnology. The company develops and manufactures biopharmaceutical products, including monoclonal antibodies, recombinant proteins, and vaccines. Key products are SCT800, SCT200, SCT-I10A, SCT400, SCT510, SCT1000, and SCT630. Sinocelltech employs 1,868 full-time staff and is listed on the stock market since June 22, 2020. It also engages in asset leasing and payment collection services. Sinocelltech Group is one of the most popular companies on Eulerpool.

Equity Details

Analyzing 's Equity

's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding 's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating 's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in ’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Sinocelltech Group stock

On Eulerpool you can find the complete historical development of The Equity Sinocelltech Group since 2006 – with annual values, charts, and detailed analysis.

The Equity's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Sinocelltech Group historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Sinocelltech Group

All Key Metrics — Sinocelltech Group